Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

Rhea-AI Summary

Journey Medical (Nasdaq: DERM), a commercial-stage pharmaceutical company specializing in FDA-approved dermatological treatments, has announced its participation in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference. The event is set to take place on Thursday, September 12, 2024 in New York City.

Claude Maraoui, President and CEO of Journey Medical, will be attending the conference to engage in one-on-one meetings with investors and industry professionals. This participation underscores the company's commitment to growth and investor relations in the pharmaceutical sector, particularly in the field of dermatology.

News Market Reaction – DERM

+3.21%

+3.21% Session move

In the trading session that priced this news, DERM gained 3.21%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SCOTTSDALE, Ariz., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, President and Chief Executive Officer, will attend one-on-one meetings at the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference, scheduled to take place on Thursday, September 12, 2024 in New York City.

About Journey Medical Corporation
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”) is a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions through its efficient sales and marketing model. The Company currently markets seven branded and two generic products that help treat and heal common skin conditions. The Journey Medical team comprises industry experts with extensive experience in developing and commercializing some of dermatology’s most successful prescription brands. Journey Medical is located in Scottsdale, Arizona and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical’s common stock is registered under the Securities Exchange Act of 1934, as amended, and it files periodic reports with the U.S. Securities and Exchange Commission (“SEC”). For additional information about Journey Medical, visit www.journeymedicalcorp.com.

Company Contact:
Jaclyn Jaffe
(781) 652-4500
ir@jmcderm.com

Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 591-2839
tplohoros@6degreespr.com

FAQ

When is Journey Medical (DERM) participating in the Lake Street Capital Markets Conference?

Journey Medical (DERM) is participating in the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference on Thursday, September 12, 2024.

Who will represent Journey Medical (DERM) at the Lake Street Capital Markets Conference?

Claude Maraoui, President and Chief Executive Officer of Journey Medical (DERM), will represent the company at the conference.

What type of meetings will Journey Medical (DERM) have at the Lake Street Capital Markets Conference?

Journey Medical (DERM) will be participating in one-on-one meetings at the Lake Street Capital Markets Conference.

Where is the Lake Street Capital Markets Conference taking place for Journey Medical (DERM)?

The Lake Street Capital Markets 8th Annual Best Ideas Growth Conference, which Journey Medical (DERM) is attending, is taking place in New York City.

What is the main focus of Journey Medical (DERM)?

Journey Medical (DERM) is a commercial-stage pharmaceutical company that primarily focuses on selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions.